XML 54 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Discontinued Operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Insurance [Abstract]    
Net revenues   $ 277
Costs, operating and other expenses   (380)
Loss from discontinued operations (103)
Net loss from discontinued operations attributable to noncontrolling interest 7
Loss from discontinued operations $ (96) [1]
[1] Does not include $106,000 gain on the deconsolidation of LifeMap Sciences recognized by AgeX. When dispositions occur in the normal course of business, gains or losses on the sale of such businesses or assets are recognized in the income statement. The gain on the sale of LifeMap Sciences is presented in the line item Gain on deconsolidation of LifeMap Sciences. There were no gains or losses resulting from the sale of businesses or assets that did not meet the criteria for a discontinued operation during the year ended December 31, 2021.